Improving Antipsychotic Use in Patients with Dementia
This session was presented on November 17, 2011
at ASCP's Annual Meeting in Phoenix, AZ.
If you have already earned credit for the live version,
you cannot earn credit again for this offering.
This presentation contains audio. Please adjust your volume accordingly.
Speakers
Assistant Professor
University of Iowa College of Public Health
Assistant Professor
University of Iowa College of Public Health
Disclosure Statement
Jeffrey C. Reist has no relevant financial relationships to disclose.
Description
This activity will describe a clinical decision aid and toolkit which have been developed to help healthcare providers make effective clinical decisions regarding the use of antipsychotics for the treatment of behavioral problems or psychosis in patients with dementia. Adapted from the AHRQ comparative effectiveness research review and summary guide on off-label use of antipsychotics it provides a clinical decision aid for providers and educational materials for both providers and consumers.
The toolkit includes pocket guides and supporting materials in print and mobile device formats and provides a range of information including assessment of potential causes, non-pharmacologic behavior management, and antipsychotic use when indicated. The toolkit also includes a guide for patients and families to facilitate shared decision making on antipsychotic use. Come to this activity to learn a stepwise approach to treatment strategies, selecting the most appropriate antipsychotic for a given patient if treatment is indicated, and providing monitoring and dosage adjustment strategies to ensure safety and efficacy.
Learning Objectives
At the conclusion of this knowledge-based activity the participant will be able to:
1. Appropriately assess behavioral problems in a patient with dementia
2. Use a stepwise approach to select treatment strategies for behavioral problems in patients with dementia.
3. Determine when an antipsychotic might be appropriate to treat behavioral problems in a patient with dementia.
4. Select the most appropriate antipsychotic for a specific patient based on co-morbidities and risk for potential adverse effects.
5. Monitor antipsychotic therapy for efficacy/safety and adjust dose/discontinue therapy as indicated.
Continuing Education
Continuing Pharmacy Education: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity (UAN: 0203-0000-11-130-H01-P) is approved for 1.25 contact hours.